Detail of > 70987-78-9
- CAS Number:
- 70987-78-9
- Name:
2-Oxiranemethanol,2-(4-methylbenzenesulfonate), (2S)-
- Superlist Name:
- (2S)-(+)-Glycidyl tosylate
- Formula:
- C10H12O4S
- Molecular Structure:
- Synonyms:
- Oxiranemethanol,4-methylbenzenesulfonate, (2S)- (9CI);Oxiranemethanol,4-methylbenzenesulfonate, (S)-;(+)-Glycidyl tosylate;(2S)-Oxiranemethanol 4-methylbenzenesulfonate;(S)-(+)-Glycidyl4-methylbenzenesulfonate;(S)-(+)-Glycidyl tosylate;(S)-(2,3-Epoxypropan-1-yl)4-methylbenzenesulfonate;(S)-Glycidol tosylate;(S)-Glycidylp-toluenesulfonate;(S)-Glycidyl tosylate;(S)-Oxiranylmethyltoluene-4-sulfonate;(S)-Toluene-4-sulfonic acid oxiranylmethyl ester;2(S)-Glycidyl tosylate;Toluene-4-sulfonic acid (S)-oxiranylmethyl ester;
- Molecular Weight:
- 228.26
- Density:
- 1.31 g/cm3
- Melting Point:
- 45-48 °C
- Boiling Point:
- 370.5 °C at 760 mmHg
- Flash Point:
- 177.9 °C
- Solubility:
- decomposes in water
- Appearance:
- white to light yellow crystal powder
- Hazard Symbols:
T, 
N, 
Xi- Risk Codes:
- 45-41-43-51/53-68
- Safety:
- 53-45-61Details
- Transport Information:
- UN 3077 9/PG 3
Related products
- 70987-78-92-Oxiranemethanol,2-(4-methylbenzenesulfonate), (2S)-
- 113826-06-52-Oxiranemethanol,2-(4-methylbenzenesulfonate), (2R)-
- 98244-48-51-Propanol,3-bromo-2-methyl-, (2S)-
- 631921-68-1Butanenitrile,2-amino-, (2S)-
- 87247-19-6(2S)-6-Methylheptan-2-ol
- 192804-36-72-Pyrrolidinemethanesulfonicacid, (2S)-
- 511254-92-5Piperazine,2-methyl-1-(phenylmethyl)-, (2S)-
- 65031-95-02-Oxiranemethanol,2-acetate, (2S)-
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(16)
United States(3)
Japan(2)
Hong Kong(1)
- Business Type:
- Importer/Exporter(17)Lab/Research institutions(3)
- Certificates:
- ISO(1) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Development of a highly cardioselective ultra short-acting b-blocker, ONO-1101
- Development of a highly cardioselective ultra short-acting b-blocker, ONO-1101.Some chemicals with cas registry numbers like 70987-78-9 are also used. Iguchi, Sadahiko; Iwamura, Hiroyuki; Nishizaki, Minoru; Hayashi, Akio; Senokuchi, Kazuhiko; Kobayashi, Kaoru; Sakaki, Katsuhito; Hachiya, Katsutoshi; Ichioka, Yumiko; Kawamura, Masanori (Minase Res. Inst., Ono Pharm.Several substances are used for example 70987-78-9 which is its cas registry number. Co., Ltd., Osaka 618, Japan). Chem. Pharm. Bull., 40(6), 1462-9 (English) 1992. CODEN: CPBTAL. ISSN: 0009-2363. DOCUMENT TYPE: Journal CA Section: 28 (Heterocyclic Compounds (More Than One Hetero Atom)) Section cross-reference(s): 1 A novel, highly cardioselective ultra short-acting b-blocker, I (ONO-1101), was developed for application in the emergency treatment of tachycardia and better control of heart rate in surgery. This agent is approx. nine times more potent in b-blocking activity in vivo and eight times more cardioselective in vitro than esmolol. This b-blocking drug has a short duration of activity, enabling rapid recovery after cessation of administration if side effects occur. It can be used safely in patients suffering from acute heart disease and represents a major therapeutic advance in the treatment of heart disease. ..
- Development of a highly cardioselective ultra short-acting b-blocker, ONO-1101
- Development of a highly cardioselective ultra short-acting b-blocker, ONO-1101.Some chemicals with cas registry numbers like 70987-78-9 are also used. Iguchi, Sadahiko; Iwamura, Hiroyuki; Nishizaki, Minoru; Hayashi, Akio; Senokuchi, Kazuhiko; Kobayashi, Kaoru; Sakaki, Katsuhito; Hachiya, Katsutoshi; Ichioka, Yumiko; Kawamura, Masanori (Minase Res. Inst., Ono Pharm.Several substances are used for example 70987-78-9 which is its cas registry number. Co., Ltd., Osaka 618, Japan). Chem. Pharm. Bull., 40(6), 1462-9 (English) 1992. CODEN: CPBTAL. ISSN: 0009-2363. DOCUMENT TYPE: Journal CA Section: 28 (Heterocyclic Compounds (More Than One Hetero Atom)) Section cross-reference(s): 1 A novel, highly cardioselective ultra short-acting b-blocker, I (ONO-1101), was developed for application in the emergency treatment of tachycardia and better control of heart rate in surgery. This agent is approx. nine times more potent in b-blocking activity in vivo and eight times more cardioselective in vitro than esmolol. This b-blocking drug has a short duration of activity, enabling rapid recovery after cessation of administration if side effects occur. It can be used safely in patients suffering from acute heart disease and represents a major therapeutic advance in the treatment of heart disease. ..
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.：Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620